Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
- Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- UMass Chan Medical SchoolResidency, Internal Medicine, 2006 - 2009
- Mayo Clinic College of Medicine and ScienceInternship, Transitional Year, 2005 - 2006
- Punjab Medical CollegeClass of 2003
Certifications & Licensure
- PA State Medical License 2022 - 2026
- TX State Medical License 2012 - 2026
- CA State Medical License 2019 - 2025
- LA State Medical License 2020 - 2022
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- First-in-Human clinical trial of a small molecule EBNA1 inhibitor, VK-2019, in patients with Epstein-Barr positive nasopharyngeal cancer, with pharmacokinetic and phar...A Dimitrios Colevas, Zahra Talebi, Elizabeth Winters, Caroline Even, Victor Ho-Fun Lee
Clinical Cancer Research. 2025-01-20 - Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer.Apostolia M Tsimberidou, Farah A Alayli, Kwame Okrah, Alexandra Drakaki, Danny N Khalil
The Journal of Experimental Medicine. 2024-10-07 - 2 citationsPromising Therapeutic Targets for Recurrent/Metastatic Anaplastic Thyroid Cancer.Abdelrahman Sherif Abdalla, Mobeen Rahman, Saad A Khan
Current Treatment Options in Oncology. 2024-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: